GOLDAN KEITH A. (Chief Financial Officer) sold 0.8% of their position (1.18K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $22.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/2/2026ACC: 0001193125-26-253603
Officer· Chief Financial Officer
Since Jun 2022
-1.18K
Net shares
Net seller
$22.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.18K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.18K
Price / share
$18.99
Trade value
$22.35K
% of position
0.8%
6/1/2026
140.43K→139.25K
Total
Net shares
−1.18K
Net value
-$22.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | S · Sale | −1.18K | $18.99 | $22.35K | 0.8% | 140.43K | 139.25K |
| Total | −1.18K | -$22.35K | ||||||
Derivative Transactions0
No derivative transactions reported